HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toshihito Tanahashi Selected Research

Platinum

12/2018CD44v-dependent upregulation of xCT is involved in the acquisition of cisplatin-resistance in human lung cancer A549 cells.
3/2015Cisplatin resistance in human lung cancer cells is linked with dysregulation of cell cycle associated proteins.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Toshihito Tanahashi Research Topics

Disease

12Neoplasms (Cancer)
10/2021 - 01/2013
8Inflammation (Inflammations)
12/2020 - 01/2009
5Hepatocellular Carcinoma (Hepatoma)
09/2021 - 01/2014
5Carcinogenesis
12/2020 - 01/2013
5Schizophrenia (Dementia Praecox)
09/2010 - 12/2007
4Stomach Neoplasms (Stomach Cancer)
10/2021 - 08/2009
4Infections
01/2018 - 10/2015
4Chronic Hepatitis B
01/2018 - 01/2012
4Type 2 Diabetes Mellitus (MODY)
02/2008 - 01/2006
3Chronic Hepatitis (Chronic Active Hepatitis)
12/2020 - 10/2015
3Colitis
01/2017 - 01/2009
3Liver Diseases (Liver Disease)
10/2015 - 01/2012
3Major Depressive Disorder (Major Depressive Disorders)
09/2010 - 05/2009
2Lung Neoplasms (Lung Cancer)
12/2018 - 03/2015
2Ulcer
12/2016 - 01/2014
2Chronic Hepatitis C
03/2016 - 01/2012
2Colonic Neoplasms (Colon Cancer)
02/2014 - 08/2012
2Obesity
11/2009 - 10/2008
2Bipolar Disorder (Manic Depressive Psychosis)
06/2009 - 05/2009
1Immunoglobulin G4-Related Disease
10/2022
1Plasma Cell Granuloma
10/2022
1Hyperphosphatemia
10/2021
1Chronic Kidney Failure (Chronic Renal Failure)
10/2021
1Adenoma (Adenomas)
01/2021
1Polyps
01/2021
1Precancerous Conditions
12/2020
1Neoplasm Metastasis (Metastasis)
01/2020
1Adenocarcinoma
01/2020
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2020
1Non-alcoholic Fatty Liver Disease
02/2019
1Fatty Liver
02/2019
1Thrombocytopenia (Thrombopenia)
01/2018
1Congenital Heart Defects (Congenital Heart Defect)
01/2018
1Hypoxia (Hypoxemia)
01/2018
1Polycythemia (Erythrocytosis)
01/2018
1Heart Diseases (Heart Disease)
01/2018
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2017
1Dermatitis
01/2017
1Stomach Ulcer (Gastric Ulcer)
01/2016
1Hemorrhage
01/2016

Drug/Important Bio-Agent (IBA)

9MicroRNAs (MicroRNA)IBA
12/2020 - 01/2012
6Proteins (Proteins, Gene)FDA Link
01/2020 - 06/2009
5Messenger RNA (mRNA)IBA
01/2020 - 01/2009
4Antiviral Agents (Antivirals)IBA
12/2020 - 08/2015
4Biomarkers (Surrogate Marker)IBA
01/2020 - 01/2012
4Cisplatin (Platino)FDA LinkGeneric
01/2020 - 03/2015
3DNA (Deoxyribonucleic Acid)IBA
01/2021 - 01/2017
3CytokinesIBA
01/2017 - 04/2006
3Indomethacin (Indometacin)FDA LinkGeneric
12/2016 - 01/2014
2Docetaxel (Taxotere)FDA Link
01/2020 - 01/2017
2Fluorouracil (Carac)FDA LinkGeneric
01/2020 - 08/2012
2LipidsIBA
02/2019 - 10/2008
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2019 - 12/2016
2PlatinumIBA
12/2018 - 03/2015
2Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2018 - 10/2015
2Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
12/2016 - 01/2014
2Protein Isoforms (Isoforms)IBA
12/2016 - 08/2009
2InterferonsIBA
03/2016 - 01/2015
2Serine (L-Serine)FDA Link
02/2014 - 06/2009
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2014 - 01/2014
2pericentrinIBA
09/2010 - 05/2009
2Oxidoreductases (Dehydrogenase)IBA
01/2009 - 12/2007
1Immunoglobulin G (IgG)IBA
10/2022
1lanthanum carbonate (Fosrenol)FDA Link
10/2021
1LanthanumIBA
10/2021
1Sorafenib (BAY 43-9006)FDA Link
09/2021
1Streptozocin (Streptozotocin)FDA Link
12/2020
1Dihydrotachysterol (AT 10)IBA
12/2020
1Small Interfering RNA (siRNA)IBA
01/2020
1Histone DemethylasesIBA
01/2020
1Choline (Choline Chloride)IBA
02/2019
1CollagenIBA
02/2019
1Methionine (L-Methionine)FDA Link
02/2019
1AntigensIBA
01/2018
1Anti-Bacterial Agents (Antibiotics)IBA
01/2017
116S Ribosomal RNAIBA
01/2017
1Indigo Carmine (Indigo Blue)IBA
01/2017
1Virulence Factors (Pathogenicity Factors)IBA
01/2017
1Cytotoxins (Cytolysins)IBA
01/2017
1OxazoloneIBA
01/2017
1Interleukin-13IBA
01/2017
1Type IV Secretion SystemsIBA
01/2017
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
01/2017
1Interleukin-4 (Interleukin 4)IBA
01/2017
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
12/2016
1InterleukinsIBA
12/2016
1Interleukin-6 (Interleukin 6)IBA
12/2016
1AlginatesIBA
01/2016
1Hemostatics (Antihemorrhagics)IBA
01/2016
1SolutionsIBA
01/2016
1Dietary FiberFDA Link
01/2016
1Neutralizing AntibodiesIBA
10/2015
1Surface Antigens (Surface Antigen)IBA
10/2015
1Indicators and Reagents (Reagents)IBA
08/2015
1NucleosidesIBA
01/2015
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2015
1Interleukin-8 (Interleukin 8)IBA
02/2014

Therapy/Procedure

4Drug Therapy (Chemotherapy)
01/2020 - 03/2015
4Therapeutics
01/2018 - 08/2015
1Combination Drug Therapy (Combination Chemotherapy)
01/2017